drugset / Trial / NCT00865085
A Relative Bioavailability Study of Citalopram 40 mg Tablets Under Fasting Conditions
RandomizedCrossoverOpen-label
Summary
The purpose of this study is to evaluate and compare the relative bioavailability, and therefore the bioequivalence of two formulations of Citalopram after a single dose administration under fasting conditions.
Timeline
- Start
- 2003-06
- Primary completion
- 2003-07
- Completion
- 2003-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Citalopram | Small molecule | 40 mg | — |
Indications
No indication recorded.